<DOC>
	<DOCNO>NCT02303587</DOCNO>
	<brief_summary>The study design investigate difference percentage presentation atelectasis , bronchiectasis , bronchiolitis obliterans , consolidation 6 month discharge treat low dose regimen methylprednisolone initiate 2 4 mg/kg/d 3 day follow taper , combine sequential treatment azithromycin versus high dose regimen methylprednisolone initiate 10 mg/kg/d 3 day follow taper , combine sequential treatment azithromycin .</brief_summary>
	<brief_title>Methylprednisolone Children With Severe Mycoplasma Pneumoniae Pneumonia ( MCMP )</brief_title>
	<detailed_description>Mycoplasma pneumonia pneumonia ( MPP ) account approximately 10-30 % childhood community-acquired pneumonia ( CAP ) China . Macrolide first choice MPP . However , progression severe pneumonia might occur despite antibiotic therapy . And patient sequelae bronchiolitis obliterans , bronchiectasis atelectasis , et al . Based inflammatory immunological mechanism , clinical evidence adjuvant corticosteroid reduce morbidity improve outcome child severe MPP . However , dosage corticosteroid vary greatly study . Therefore , large prospective study need define benefit high-dose corticosteroid therapy MPP . Patients randomize two group : low dose group high dose group . The low dose group receive methylprednisolone 2 4 mg/kg/d 3 day follow taper 9 day , combine sequential treatment azithromycin . The high dose group receive methylprednisolone 10 mg/kg/d 3 day follow taper 9 day , combine sequential treatment azithromycin . After discharge , patient group follow 1 , 3 , 6 month . The number pulmonary lesion , include atelectasis , bronchiectasis , bronchiolitis obliterans , consolidation , 6 month discharge compare two group . The number adverse event , hyperglycemia , hypertension , increase intraocular pressure , compare two group . The trial complete 35 month , 630 subject recruit 9 hospital partnership clinical research collaboration National Clinical Research Center Respiratory Diseases .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pleuropneumonia</mesh_term>
	<mesh_term>Mycoplasma Infections</mesh_term>
	<mesh_term>Pneumonia , Mycoplasma</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Severe pneumonia diagnosis criterion base `` Zhu Futang Practical Pediatrics '' ( 7th Edition ) `` guideline management communityacquired pneumonia child China '' ( Chinese Journal Pediatrics , 2013 , 51:745752 , 856862 ) . Severe pneumonia define pneumonia one following : 1. fever &gt; 38.5℃ , 2. increase respiratory rate ( infant &gt; 70/min，older child &gt; 50/min ) , 3. dyspnea , 4. cyanosis , 5. multilobe involvement ≥ 2/3 lung involvement , 6. extrapulmonary complication , 7. pleural effusion , （8）Transcutaneous oxygen saturation ≤92 % . Severe mycoplasma pneumoniae pneumonia define fulfil follow : 1. fulfill criterion severe pneumonia ; 2 . Serum Mycoplasma pneumoniae antibody≥ 1:160 . 3 . Macrolide use least 7 day . S Subject/Guardian inform consent . Subject exclude one following : evidence bacterial pneumonia ; evidence viral pneumonia ; evidence fugal pneumonia ; evidence pulmonary tuberculosis ; respiratory failure require mechanical ventilation ; hemophagocytic syndrome ; liver failure renal insufficiency ; congenital heart disease ; heart failure ; kidney disease ; connective tissue disease ; immunodeficiency ; tumor ; history hypertension diabetes mellitus ; recurrent respiratory tract infection ; congenital bronchopulmonary dysplasia ; increase intraocular pressure ; history use glucocorticosteroid ≥1 week previous 3 month ; contraindication glucocorticosteroids azithromycin ; use immunosuppressant randomization ; undergoing trial medication instrument .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Severe mycoplasma pneumoniae</keyword>
	<keyword>pneumonia</keyword>
	<keyword>child</keyword>
</DOC>